Nurix Therapeutics's total assets for Q2 2025 were $591.55M, a decrease of -3.82% from the previous quarter. NRIX total liabilities were $143.95M for the fiscal quarter, a 7.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.